Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
5
×
drugs
5
×
life sciences
national blog main
national top stories
roche
5
×
boston blog main
boston top stories
clinical trials
detroit blog main
detroit top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boulder/denver blog main
boulder/denver top stories
deals
gene therapy
indiana blog main
indiana top stories
spark therapeutics
car-t
cell therapy
fda
financing
ginkgo bioworks
novartis
What
fda
access
admits
advanced
ago
ahead
american
annual
approved
asco
ash
big
bio
biotechs
blood
borne
branded
cancer
cancers
capacity
car
cell
choices
classes
combinator
commissioner
companies
conference
consolidation
consumers
costly
counterweight
crispr
deeper
diego
dna
drug
drugs
dug
elevatebio
Language
unset
Current search:
drugs
×
cancer
×
roche
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More